Hot Deals:
adtech 73.00 (1.39 %) agarwal bolts 1,200.00 (0.00 %) amol minechem 601.00 (0.17 %) anand i-power 20.00 anglo french drugs 745.00 (-0.67 %) apl metals 40.00 (-2.44 %) arkfin investments 50.00 arohan 150.00 (3.45 %) assam carbon 215.00 (2.38 %) atlas copco 10,000.00 (1.01 %) auckland international 129.00 (-0.77 %) av thomas 16,800.00 (0.00 %) axles 500.00 (2.04 %) balmer lawrie 202.00 (1.00 %) bharat hotels 300.00 (3.45 %) bima mandi 235.00 (-2.08 %) bira 600.00 (0.84 %) boat 1,350.00 (1.50 %) c & s electric 600.00 (1.69 %) cable corporation 13.00 (-0.76 %) capgemini 11,500.00 (0.88 %) care health 179.00 (-0.56 %) carrier aircon 535.00 (1.90 %) cial 285.00 (1.79 %) csk 183.00 (-0.54 %) dalmia refract 195.00 (2.63 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 425.00 (2.66 %) electronica plastic 2,100.00 (-0.99 %) elgi ultra 400.00 elofic 2,050.00 (-0.97 %) esl steel 45.00 (2.27 %) fincare business 72.00 (2.86 %) fincare sfbl 202.00 (1.00 %) finopaytech 156.00 (0.65 %) flipkart india 231,001.00 (0.00 %) frick india 15,800.00 (3.95 %) gkn driveline 1,350.00 (3.05 %) go digit general insurance ltd 354.00 (1.14 %) godavari bio 71.00 (1.43 %) goodluck defence 240.00 (-1.23 %) group pharma 300.00 gynofem healthcare 81.00 (1.25 %) hdb financial 1,050.00 (5.53 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,000.00 (1.85 %) hella india 810.00 (1.25 %) hero fincorp 1,685.00 (-0.12 %) hexaware 885.00 (0.57 %) hicks 1,450.00 (2.11 %) hira ferro 155.00 (3.33 %) honeywell electrical 4,500.00 (2.27 %) ikf finance 243.00 (1.25 %) incred financial 109.00 (3.81 %) incred holdings 151.00 (0.67 %) india carbon 1,175.00 (0.43 %) india exposition 140.00 (3.70 %) indian potash 2,900.00 (-1.69 %) indo alusys 25.75 (-0.96 %) indofil 790.00 (-1.25 %) infinite computer 405.00 (1.25 %) inkel 21.50 (2.38 %) ixigo 143.00 (-1.38 %) jana small finance bank 75.00 kel 625.00 (1.63 %) kial 122.00 (-2.40 %) klm axiva 15.00 (-1.32 %) kurlon limited 1,250.00 (2.46 %) lava 70.00 (-1.41 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 1,333.00 (-1.26 %) martin & harris 1,020.00 (0.99 %) merino 3,250.00 (1.56 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 421.00 (-0.94 %) mobikwik 570.00 (-0.87 %) mohan meakin 1,950.00 (2.63 %) mohfl 12.80 (-1.54 %) msei 1.14 (-0.87 %) msil 35.00 (-2.78 %) nayara energy 480.00 (1.05 %) nayara energy ncd 285.00 (1.79 %) ncdex 275.00 ncl buildtek 260.00 (1.56 %) ncl holdings 85.00 (3.66 %) nsdl 777.00 (3.60 %) nse 4,500.00 (-0.99 %) orbis financial 280.00 (1.82 %) oswal minerals 60.10 (-1.48 %) otis 3,770.00 (0.53 %) oyo 55.00 (-1.79 %) panasonic appliances 211.00 (0.48 %) paymate india 514.00 (-0.19 %) pharmeasy 10.00 (1.01 %) pharmed limited 480.00 (2.13 %) philips domestic 600.00 (1.69 %) philips india 920.00 (-0.54 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 275.00 (-1.79 %) rapido 16,650.00 (0.03 %) rasoi 31,500.00 (0.32 %) reliance gic 480.00 (1.05 %) resins plastics 415.00 (-1.89 %) ring plus aqua 530.00 (0.95 %) rrl 1,275.00 (2.00 %) rrp s4e innovation 282.00 (0.71 %) sab miller 375.00 (-1.32 %) sbi amc 1,670.00 (1.21 %) sbi general insurance 600.00 (3.45 %) scottish assam 440.00 (-1.35 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,400.00 (3.70 %) smile microfinance 54.00 (3.85 %) sportskeeda 3,303.00 sterlite power 522.00 (-0.57 %) studds 975.00 (0.52 %) svsml 315.00 (2.94 %) swiggy 345.00 (-1.43 %) t stanes 770.00 (1.99 %) tata capital 920.00 (2.22 %) teesta agro 77.00 (-6.21 %) trl krosaki 1,290.00 (-0.77 %) urban tots 52.00 (4.00 %) utkarsh coreinvest 285.00 (-1.72 %) vadilal dairy 10.00 vikram solar 230.00 (-4.17 %) waree energies 1,880.00 (1.62 %)
×

Martin & Harris Unlisted Share Price

Martin And Harris Laboratories Limited Fundamentals

Company Name
Martin And Harris Laboratories Limited
Scrip Name
Martin & Harris
Last Traded Price
1,020.00
+ 0.99 %
Sector
Pharma
PAN No.
AABCM0832A
Face Value
10
No. of Outstanding Shares
3,996,040
EPS
442.598
PE ratio
2.305
Market Capitalization
407.60 Crore
Book value
1115.133
P/BV
0.9147
ISIN No.
INE03VV01015
Available on
nsdl
ROFR Require
No
Day High
1,020.00
Day Low
1,020.00
52 Week High
1,125.00
52 Week Low
925.00
Lifetime High
2,800.00
Lifetime Low
205.00

Martin & Harris Price Performance

Martin and Harris Laboratories Limited Unlisted Share – Company Overview

MARTIN AND HARRIS LABORATORIES LIMITED was first established in 1996 and is based in Gurgaon, Haryana. The company is a part of Apeejay Group, which is India’s oldest and largest Conglomerates. Apeejay Group is a leading Industrial & Investment house with businesses in Automotive, Chemicals & Plastics, Distribution, Logistics & Retail, Pharmaceuticals & life sciences, real estate, and international trading and a nascent presence in IT, merchant banking & financial services and publishing.

Martin and Harris Laboratories Limited is primarily engaged in the business of manufacturing pharmaceuticals, medicinal chemicals & botanical products. The company intensively focuses on drugs used for Hyper Tension, High blood pressure, and heart attack. Apart from its primary business, the company also undertakes fund management through investment in different avenues like mutual funds, equity, etc.

Martin and Harris Laboratories Limited has two units located at Roorkee, Uttarakhand, and Una in Himachal Pradesh. The company is continuously striving to expand its manufacturing facilities and meet global standards.

The company was awarded ‘Best Pharma Excellence awards’ in 2018 by ASSOCHAM India.

Martin And Harris Laboratories Limited Incorporation Details

CIN of Martin and Harris Laboratories

U24239HR1993PLC033630

Registration Date of Martin and Harris Laboratories

22 July 1993

Category/Sub-category of Martin and Harris Laboratories

Company Limited by Shares

Martin and Harris Laboratories Registered office address 

NH-8, Delhi Jaipur Highway,

Village, Pachgaon (Fazalwas),

District Gurgaon, Haryana

Martin and Harris Laboratories Registrar and Transfer Agent address and contact details

NA

Martin And Harris Laboratories Limited Principal Business Activities

Name and Description of main products/services

NIC Code of the product/service

% to total turnover of the Company

Manufacture of Pharmaceutical, Medicinal Chemical & Botanical Products

210

52.03%

Fund management activities

663

47.97%

Martin And Harris Laboratories Limited Board of Directors

MR. S. L. LAAD

MR. G. K. NIGAM

MR. AJAY GROVER

MR. H. S. THAKUR

Martin And Harris Laboratories Particular of Subsidiary Companies

Name of the Company

% of shares held

Delite Infrastructure Private limited

100.00%

Martin And Harris Laboratories Limited Shareholding Pattern (As on 31-03-2020)

S. No.

Shareholders’ Name

Number of shares

% of total Shares of the company

1

Promoters Shareholding

140

0.004%

2

Public Shareholding

39,95,900

99.996%

 

Total

39,96,040

100.00%

Industry Outlook

 Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of the global demand for various vaccines, 40% of generic demands in the USA, and 25% of all the medicines in the United Kingdom. Excellent Research & Development, low cost of labor, availability of management and technical personnel, and local equipment’s availability has helped India to manufacture pharma products at a very low cost.

The Indian healthcare market may see a 3 fold jump in terms of value to reach US$ 372 billion by FY 2022. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID 19. India aims to achieve vaccination for COVID-19 of 30 Crore people in the next few months.

Export of Pharmaceuticals products from India stood at US$ 16.8 billion in FY 2020 and US$ 2.07 billion in the month of October 2020. In the first 3 quarters of FY 2021, India exported pharmaceuticals worth US$ 15.86 billion. India supplied around 45 tons and 400 million tablets of hydroxychloroquine to around 114 countries globally to treat the covid patients in the initial stage of the covid-19 pandemic. Exports in FY 2021 of Indian pharma products are expected to cross US$ 24 billion, increasing by over 16% when compared to FY 2020.

After the onset of COVID 19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector.

Annual Report

Martin And Harris Annual Report 2019-20

Download

Martin & Harris Annual Report 2021-2022

Download

Recent News

Wealth Wisdom - WWIPL
Support Megha Support Neha